Gastroenterology 94 (5 Part 2):A111.[Web of Science ] , [Google Scholar]) discovered that PGN not only induced lesions in Guinea pigs, but also caused degeneration of the ICCs in the PSE
As Nutrigenomics Coaches we are happy to advise on product selection, dosing questions and how to integrate the system with diet, exercise and lifestyle modifications
The key question isn't whether HIPAA applies - it does, as a baseline floor for any telehealth platform
Prevention is always best
10.3389/fnut.2022.841282 81
"Both semaglutide and tirzepatide are well-known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes." Despite promising results from existing randomized controlled trials of semaglutide and tirzepatide in those with obesity-related HFpEF, regulatory authorities and professional societies have not approved or endorsed the use of these drugs for HFpEF, due in part to the studies relatively small sample sizes and unknown generalizability
